- Systematic review and meta-analysis of five placebo-controlled RCTs (335 participants) testing perioperative pregabalin in adults undergoing elective lumbar spine surgery.
- Pregabalin was compared with placebo, with the primary outcome being pain intensity at 3 months, pooled across four trials (275 participants).
- Pregabalin did not reduce 3-month pain intensity (SMD 0.03, 95% CI -0.41 to 0.47; I² 69%; low certainty).
- Functional disability was lower with pregabalin (SMD -0.51, 95% CI -0.86 to -0.16), but the differences fell below minimal important change thresholds, with very low certainty.
Neuro
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- A Bayesian systematic review and meta-analysis of 54 studies, including 367,896 critically ill adults, examined new-onset atrial fibrillation in general ICUs and high-dependency units.
- It compared post-discharge systemic thromboembolism in patients with and without new-onset atrial fibrillation, with follow-up ranging from 1.5 months to 5 years.
- Pooled NOAF incidence was 10.6% (95% CrI 8.6-12.9%), and post-discharge thromboembolism risk was 7.1% (95% CrI 4.5-11.0%). Relative risk was 1.94 (95% CrI 1.23-3.29) across six studies, rising to 2.01 with adjustment.
- Anticoagulation use was low, at 32.9% in-hospital and 35.9% post-discharge, and 23.9% of patients with NOAF were later diagnosed with atrial fibrillation.
- Systematic review and meta-analysis of seven retrospective cohorts (28,525 patients) comparing lumbar fusion patients with and without preoperative GLP-1RA exposure.
- Six of the seven studies used propensity score matching or another matching strategy to balance the comparison groups.
- No significant association with reoperation or revision (OR 0.74, 95% CI 0.44-1.24; P = 0.25) or postoperative infection (OR 0.83, 95% CI 0.68-1.00; P = 0.05).
- The authors found no signal of increased postoperative risk and called for prospective studies with standardized exposure definitions and perioperative management protocols.
- Meta-analysis of 25 randomized controlled trials (3344 patients) comparing perioperative ketamine or esketamine with placebo or standard care for postoperative delirium.
- Ketamine (9 trials) and esketamine (16 trials) were compared with control, with subgroup analyses by dose, regimen, surgery type and timing of assessment.
- Both agents reduced postoperative delirium risk: ketamine RR 0.69 (95% CI 0.49-0.98, P = .04) and esketamine RR 0.58 (95% CI 0.36-0.95, P = .03).
- Dizziness risk rose (RR 1.45, 95% CI 1.14-1.84), and trial sequential analysis found the evidence inconclusive, so the authors call for large multicenter RCTs.
- Systematic review and meta-analysis of 13 randomized trials including 3,861 adult ICU patients, comparing open or flexible family visiting with restricted visiting.
- Delirium was the primary outcome; secondary outcomes were invasive ventilation duration, ICU length of stay, hospital-acquired infections, and ICU mortality.
- Open or flexible presence reduced delirium (RR 0.48; 95% CI 0.29-0.81; low certainty) and invasive ventilation duration (MD -0.36 d; 95% CI -0.46 to -0.26 d; low certainty).
- No effect was seen on ICU length of stay, infections, or ICU mortality; the authors note low certainty of evidence and substantial heterogeneity.
AI summary not available. Read the source abstract on PubMed.
AI summary not available. Read the source abstract on PubMed.
- Systematic review and meta-analysis of 21 randomized controlled trials including 1271 adults undergoing spinal surgery.
- The exposure was perioperative intravenous magnesium sulfate, with a control group for comparison.
- Magnesium reduced 24-hour pain scores (MD -0.55, 95% CI -1.01 to -0.10, P = 0.02) and opioid consumption (MD -4.95 mg, 95% CI -8.74 to -1.15 mg, P = 0.01).
- Magnesium was associated with less postoperative nausea and vomiting but more hypotension, and with prolonged time to follow commands and recover orientation.
- Systematic review and meta-analysis of 15 RCTs including 3,274 older adults undergoing cardiac surgery.
- Perioperative dexmedetomidine was compared with placebo or alternative sedative or analgesic regimens for preventing postoperative delirium.
- Dexmedetomidine lowered postoperative delirium incidence (RR 0.70, 95% CI 0.56 to 0.86, p = 0.001; moderate certainty) but increased reported bradycardia (RR 2.08, 95% CI 1.31 to 3.31).
- The benefit appeared larger against active comparators than placebo or saline. The delirium duration reduction (MD -1.12 days) was low certainty with high heterogeneity.
- Meta-analysis with trial sequential analysis of RCTs in pediatric ENT surgery; ten trials were identified and six (414 patients) were pooled.
- Low-dose propofol given before extubation was compared with placebo for emergence agitation and related outcomes.
- Propofol reduced emergence agitation incidence (RR 0.57, 95% CI 0.42-0.78) and severity (MD -3.94, 95% CI -5.74 to -2.13).
- Time to extubation was slightly longer (MD 1.8 min, 95% CI 1.4-2.3), with no difference in recovery time or PACU length of stay.
AI summary not available. Read the source abstract on PubMed.
- Systematic review and meta-analysis of eight retrospective cohort studies, covering 311,402 ACDF patients including 8,182 GLP-1RA users matched to non-users.
- Compared perioperative GLP-1RA use with non-use for pseudarthrosis, reoperation, dysphagia, deep vein thrombosis, and readmission after ACDF.
- Lower pseudarthrosis odds at 6 months (OR 0.60, 95% CI 0.52 to 0.71), 12 months (OR 0.62, 0.53 to 0.73), and 24 months (OR 0.67, 0.57 to 0.79).
- Findings for reoperation, dysphagia, deep vein thrombosis, and readmission were heterogeneous and inconsistent, so evidence on other complications is inconclusive.
- Systematic review and meta-analysis of 8 randomized trials with 916 children receiving sevoflurane-based general anesthesia, comparing esketamine with placebo.
- Esketamine was compared with placebo for preventing emergence delirium, with no significant differences across dosing, surgery type, route, or timing.
- Emergence delirium was reduced with esketamine (RR 0.35; 95% CI 0.26-0.48; p<0.0001), and postoperative pain scores were lower (SMD -0.58).
- Extubation was modestly prolonged by 1.72 minutes, and nausea and vomiting were reduced (RR 0.69); certainty was moderate for most outcomes, low for extubation time.
- Systematic review and meta-analysis of 17 randomized controlled trials including 1871 children undergoing surgery, comparing music with no-music controls.
- Music was compared with no-music controls across preoperative anxiety, postoperative pain, heart rate, and blood pressure outcomes.
- Music significantly reduced preoperative anxiety (SMD -2.03, 95% CI -3.19 to -0.86) and postoperative pain (SMD -0.64, 95% CI -1.01 to -0.27).
- Heart rate and mean arterial pressure also fell (MD -12.92 bpm; MD -8.41 mmHg), with no significant effect on systolic pressure.
- Systematic review and meta-analysis of five randomized controlled trials, including 646 adults undergoing brain surgery, with searches run through April 2025.
- Evaluated perioperative dexmedetomidine, given as a loading dose followed by a maintenance infusion, for preventing postoperative delirium.
- The pooled risk ratio was 0.47 (95% CI 0.35-0.63; p < 0.00001), a 53% reduction in delirium risk, with no heterogeneity (I2 = 0%).
- Subgroups showed similar effects across brain tumor and other cranial procedures, adverse events were comparable and mostly mild, and the authors call for multicenter trials.
- Systematic review and meta-analysis of 21 studies including 5725 surgical patients aged 18 or older, with 11 non-cardiac and 10 cardiac surgery studies, searched to March 2024.
- Pooled preoperative prevalence of impairment was compared across six cognitive domains, and perioperative changes in those domains were examined.
- Preoperative impairment was highest in executive function at 18% (95% CI, 13%-24%), followed by visuospatial function at 16% and attention/working memory/processing speed at 14%.
- Postoperative impairment peaked at 1 week (attention 35%, 95% CI 4%-66%) and fell by 3 months, with some confidence intervals crossing zero.